Pfizer on Tuesday, February 1, asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. By Lauran Neergaard and Matthew Perrone, Associated Press In an extraordinary move, the Food and Drug Administration had […]
